Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study

被引：0
|
作者：
Bibian M. E. Tullemans
Sanne L. N. Brouns
Frauke Swieringa
Siamack Sabrkhany
Franchette W. P. J. van den Berkmortel
Natascha A. J. B. Peters
Peter de Bruijn
Stijn L. W. Koolen
Johan W. M. Heemskerk
Maureen J. B. Aarts
Marijke J. E. Kuijpers
机构：
[1] Maastricht University,Cardiovascular Research Institute Maastricht, Department of Biochemistry
[2] Synapse Research Institute,Cardiovascular Research Institute Maastricht, Department of Physiology
[3] Maastricht University,Department of Medical Oncology
[4] Zuyderland Medical Centre,Department of Internal Medicine
[5] Sint Jans Gasthuis,Department of Medical Oncology, Erasmus MC Cancer Institute
[6] Erasmus University Medical Centre,Thrombosis Expertise Centre, Heart and Vascular Centre
[7] Department of Pharmacy,undefined
[8] Erasmus University Medical Centre,undefined
[9] Department of Medical Oncology,undefined
[10] Maastricht University Medical Centre+,undefined
[11] Maastricht University Medical Centre,undefined
来源：
BMC Cancer | / 22卷
关键词：
Platelet count; Platelet aggregation; Sunitinib; Tyrosine kinase inhibitor; Renal cell carcinoma; cancer; Patients; Plasma; Serum; Bleeding;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 41 条
  • [1] Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study
    Tullemans, Bibian M. E.
    Brouns, Sanne L. N.
    Swieringa, Frauke
    Sabrkhany, Siamack
    van den Berkmortel, Franchette W. P. J.
    Peters, Natascha A. J. B.
    de Bruijn, Peter
    Koolen, Stijn L. W.
    Heemskerk, Johan W. M.
    Aarts, Maureen J. B.
    Kuijpers, Marijke J. E.
    BMC CANCER, 2022, 22 (01)
  • [2] Shrinkage of Prostate Volume in Sunitinib-treated Patients with Renal Cell Carcinoma
    Hatano, Takashi
    Ishii, Gen
    Endo, Katsuhisa
    Kishimoto, Koichi
    Egawa, Shin
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (12) : 1282 - 1285
  • [3] Angiogenesis markers in sunitinib-treated clear-cell renal carcinoma patients.
    Kontovinis, Loukas
    Papazisis, Konstantinos
    Touplikioti, Panagiota
    Mouratidou, Despoina
    Boutis, Lazaros
    Kortsaris, Alexandros
    CANCER RESEARCH, 2008, 68 (09)
  • [4] Association between diabetes mellitus and the survival of sunitinib-treated patients with metastatic renal cell carcinoma.
    Suyama, Takahito
    Fujimoto, Ayumi
    Kanesaka, Manato
    Hou, Kyokushin
    Araki, Kazuhiro
    Masuda, Hiroshi
    Kojima, Satoko
    Sazuka, Tomokazu
    Nakamura, Kazuyoshi
    Nihei, Naoki
    Ichikawa, Tomohiko
    Naya, Yukio
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?
    P. Ivanyi
    J. Koenig
    A. Trummer
    J. F. Busch
    C. Seidel
    C. W. Reuter
    A. Ganser
    V. Grünwald
    World Journal of Urology, 2016, 34 : 909 - 915
  • [6] Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma
    Izzedine, H.
    Derosa, L.
    Le Teuff, G.
    Albiges, L.
    Escudier, B.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1128 - 1133
  • [7] Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?
    Ivanyi, P.
    Koenig, J.
    Trummer, A.
    Busch, J. F.
    Seidel, C.
    Reuter, C. W.
    Ganser, A.
    Gruenwald, V.
    WORLD JOURNAL OF UROLOGY, 2016, 34 (07) : 909 - 915
  • [8] Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
    Billemont, B.
    Medioni, J.
    Taillade, L.
    Helley, D.
    Meric, J. B.
    Rixe, O.
    Oudard, S.
    BRITISH JOURNAL OF CANCER, 2008, 99 (09) : 1380 - 1382
  • [9] Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
    B Billemont
    J Medioni
    L Taillade
    D Helley
    J B Meric
    O Rixe
    S Oudard
    British Journal of Cancer, 2008, 99 : 1380 - 1382
  • [10] IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
    Xu, C-F
    Johnson, T.
    Garcia-Donas, J.
    Choueiri, T. K.
    Sternberg, C. N.
    Davis, I. D.
    Bing, N.
    Deen, K. C.
    Xue, Z.
    McCann, L.
    Esteban, E.
    Whittaker, J. C.
    Spraggs, C. F.
    Rodriguez-Antona, C.
    Pandite, L. N.
    Motzer, R. J.
    BRITISH JOURNAL OF CANCER, 2015, 112 (07) : 1190 - 1198
12345